[1]
|
Tan, L., Mai, D., Zhang, B., et al. (2019) PIWI-Interacting RNA-36712 Restrains Breast Cancer Progression and Chemoresistance by Interaction with SEPW1 Pseudogene SEPW1P RNA. Molecular Cancer, 18, 9.
https://doi.org/10.1186/s12943-019-0940-3
|
[2]
|
Tian, W., Yao, Y., Fan, G., et al. (2019) Changes in Lipid Profiles during and after (Neo)adjuvant Chemotherapy in Women with Early-Stage Breast Cancer: A Retrospective Study. PLOS ONE, 14, e0221866.
https://doi.org/10.1371/journal.pone.0221866
|
[3]
|
Hwang, S.O., Lee, S.W., Kim, H.J., et al. (2013) The Compara-tive Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer. Journal of Breast Cancer, 16, 315-321. https://doi.org/10.4048/jbc.2013.16.3.315
|
[4]
|
Li, Z.Y., Zhang, Z., Cao, X.Z., et al. (2020) Platinum-Based Neo-adjuvant Chemotherapy for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. Journal of Interna-tional Medical Research, 48.
https://doi.org/10.1177/0300060520964340
|
[5]
|
Von Minckwitz, G., Schneeweiss, A., Loibl, S., et al. (2014) Ne-oadjuvant Carboplatin in Patients with Triple-Negative and HER2-Positive Early Breast Cancer (GeparSixto; GBG 66): A Randomised Phase 2 Trial. The Lancet Oncology, 15, 747-756. https://doi.org/10.1016/S1470-2045(14)70160-3
|
[6]
|
Song, Y.X., Xu, Z., Liang, M.X., et al. (2022) Diagnostic Accuracy of De-Escalated Surgical Procedure in Axilla for Node-Positive Breast Cancer Patients Treated with Neoadju-vant Systemic Therapy: A Systematic Review and Meta-Analysis. Cancer Medicine, 11, 4085-4103. https://doi.org/10.1002/cam4.4769
|
[7]
|
Krag, D.N. anderson, S.J., Julian, T.B., et al. (2010) Sentinel-Lymph-Node Resection Compared with Conventional Axillary-Lymph-Node Dissection in Clinically Node-Negative Patients with Breast Cancer: Overall Survival Findings from the NSABP B-32 Randomised Phase 3 Trial. The Lancet Oncology, 11, 927-933.
https://doi.org/10.1016/S1470-2045(10)70207-2
|
[8]
|
Kim, H., Lee, S.B., Nam, S.J., et al. (2021) Survival of Breast-Conserving Surgery plus Radiotherapy versus Total Mastectomy in Early Breast Cancer. Annals of Surgical On-cology, 28, 5039-5047.
https://doi.org/10.1245/s10434-021-09591-x
|
[9]
|
Ge, I., Erbes, T. and Juhasz-Boss, I. (2022) Prognostic Value and Management of Regional Lymph Nodes in Locoregional Breast Cancer Recurrence: A Systematic Review of the Lit-erature. Archives of Gynecology and Obstetrics, 306, 943-957. https://doi.org/10.1007/s00404-021-06352-9
|
[10]
|
Voogd, A.C., Coebergh, J.W., Repelaer Van Driel, O.J., et al. (2000) The Risk of Nodal Metastases in Breast Cancer Patients with Clinically Negative Lymph Nodes: A Popula-tion-Based Analysis. Breast Cancer Research and Treatment, 62, 63-69. https://doi.org/10.1023/A:1006447825160
|
[11]
|
Pezner, R.D., Patterson, M.P., Hill, L.R., et al. (1986) Arm Lymphedema in Patients Treated Conservatively for Breast Cancer: Relationship to Patient Age and Axillary Node Dis-section Technique. International Journal of Radiation Oncology, Biology, Physics, 12, 2079-2083. https://doi.org/10.1016/0360-3016(86)90005-2
|
[12]
|
Haigh, P.I., Hsueh, E.C. and Giuliano, A.E. (1999) Sentinel Lymphadenectomy in Breast Cancer. Breast Cancer, 6, 139-144. https://doi.org/10.1007/BF02966922
|
[13]
|
Zhou, Y., Pu, S., Jiang, S., et al. (2022) The Prognostic Significance of Further Axillary Dissection for Sentinel Lymph Node Micrometastases in Female Breast Cancer: A Competing Risk Analysis Using the SEER Database. Frontiers in Oncolo-gy, 12, Article ID: 1012646. https://doi.org/10.3389/fonc.2022.1012646
|
[14]
|
Mcmasters, K.M., Giuliano, A.E., Ross, M.I., et al. (1998) Sentinel-Lymph-Node Biopsy for Breast Cancer—Not Yet the Standard of Care. The New Eng-land Journal of Medicine, 339, 990-995.
https://doi.org/10.1056/NEJM199810013391410
|
[15]
|
Giuliano, A.E., Jones, R.C., Brennan, M., et al. (1997) Sen-tinel Lymphadenectomy in Breast Cancer. Journal of Clinical Oncology, 15, 2345-2350. https://doi.org/10.1200/JCO.1997.15.6.2345
|
[16]
|
Mcmasters, K.M., Tuttle, T.M., Carlson, D.J., et al. (2000) Sen-tinel Lymph Node Biopsy for Breast Cancer: A Suitable Alternative to Routine Axillary Dissection in Multi-Institutional Practice When Optimal Technique Is Used. Journal of Clinical Oncology, 18, 2560-2566. https://doi.org/10.1200/JCO.2000.18.13.2560
|
[17]
|
Veronesi, U., Paganelli, G., Viale, G., et al. (2003) A Random-ized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer. The New England Journal of Medicine, 349, 546-553.
https://doi.org/10.1056/NEJMoa012782
|
[18]
|
Krag, D.N. anderson, S.J., Julian, T.B., et al. (2007) Technical Out-comes of Sentinel-Lymph-Node Resection and Conventional Axillary-Lymph-Node Dissection in Patients with Clinically Node-Negative Breast Cancer: Results from the NSABP B-32 Randomised Phase III Trial. The Lancet Oncology, 8, 881-888.
https://doi.org/10.1016/S1470-2045(07)70278-4
|
[19]
|
Crane-Okada, R., Wascher, R.A., Elashoff, D., et al. (2008) Long-Term Morbidity of Sentinel Node Biopsy versus Complete Axillary Dissection for Unilateral Breast Cancer. An-nals of Surgical Oncology, 15, 1996-2005.
https://doi.org/10.1245/s10434-008-9909-y
|
[20]
|
Purushotham, A.D., Upponi, S., Klevesath, M.B., et al. (2005) Morbidity after Sentinel Lymph Node Biopsy in Primary Breast Cancer: Results from a Randomized Controlled Trial. Journal of Clinical Oncology, 23, 4312-4321.
https://doi.org/10.1200/JCO.2005.03.228
|
[21]
|
Dihge, L., Bendahl, P.O. and Ryden, L. (2017) Nomograms for Preoperative Prediction of Axillary Nodal Status in Breast Cancer. British Journal of Surgery, 104, 1494-1505. https://doi.org/10.1002/bjs.10583
|
[22]
|
Shoup, M., Malinzak, L., Weisenberger, J., et al. (1999) Predictors of Axil-lary Lymph Node Metastasis in T1 Breast Carcinoma. The American Surgeon, 65, 748-752. https://doi.org/10.1177/000313489906500810
|
[23]
|
Bevilacqua, J.L., Kattan, M.W., Fey, J.V., et al. (2007) Doctor, What Are My Chances of Having a Positive Sentinel Node? A Validated Nomogram for Risk Estimation. Journal of Clinical Oncology, 25, 3670-3679.
https://doi.org/10.1200/JCO.2006.08.8013
|
[24]
|
Hindié, E., Groheux, D., Brenot-Rossi, I., et al. (2011) The Senti-nel Node Procedure in Breast Cancer: Nuclear Medicine as the Starting Point. Journal of Nuclear Medicine, 52, 405-414. https://doi.org/10.2967/jnumed.110.081711
|
[25]
|
Schwartz, G.F., Giuliano, A.E., Veronesi, U., et al. (2002) Pro-ceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer, 94, 2542-2551. https://doi.org/10.1002/cncr.10539
|
[26]
|
Lyman, G.H., Temin, S., Edge, S.B., et al. (2014) Sentinel Lymph Node Biopsy for Patients with Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology, 32, 1365-1383. https://doi.org/10.1200/JCO.2013.54.1177
|
[27]
|
Montgomery, L.L., Thorne, A.C., Van Zee, K.J., et al. (2002) Isosulfan Blue Dye Reactions during Sentinel Lymph Node Mapping for Breast Cancer. Anesthesia & Analgesia, 95, 385-388.
https://doi.org/10.1213/00000539-200208000-00026
|
[28]
|
Barthelmes, L., Goyal, A., Newcombe, R.G., et al. (2010) Adverse Reactions to Patent Blue V Dye—The NEW START and ALMANAC Experience. European Journal of Surgical Oncology, 36, 399-403.
https://doi.org/10.1016/j.ejso.2009.10.007
|
[29]
|
Gentilini, O. and Veronesi, U. (2012) Abandoning Sentinel Lymph Node Biopsy in Early Breast Cancer? A New Trial in Progress at the European Institute of Oncology of Milan (SOUND: Sentinel Node vs Observation after Axillary Ultrasound). Breast, 21, 678-681. https://doi.org/10.1016/j.breast.2012.06.013
|
[30]
|
Tavassoli, F.A., Devilee, P., et al. (2003) Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC, Lyon.
|
[31]
|
Wang, J., Mittendorf, E.A., Sahin, A.A., et al. (2014) Outcomes of Sentinel Lymph Node Dissection Alone vs. Axillary Lymph Node Dissection in Early Stage Inva-sive Lobular Carcinoma: A Retrospective Study of the Surveillance, Epidemiology and End Results (SEER) Database. PLOS ONE, 9, e89778.
https://doi.org/10.1371/journal.pone.0089778
|
[32]
|
Donker, M., Van Tienhoven, G., Straver, M.E., et al. (2014) Radiotherapy or Surgery of the Axilla after a Positive Sentinel Node in Breast Cancer (EORTC 10981-22023 AMAROS): A Randomised, Multicentre, Open-Label, Phase 3 Non-Inferiority Trial. The Lancet Oncology, 15, 1303-1310. https://doi.org/10.1016/S1470-2045(14)70460-7
|
[33]
|
Fisher, C.S., Margenthaler, J.A., Hunt, K.K., et al. (2020) The Landmark Series: Axillary Management in Breast Cancer. Annals of Surgical Oncology, 27, 724-729. https://doi.org/10.1245/s10434-019-08154-5
|
[34]
|
Houssami, N., Ciatto, S., Turner, R.M., et al. (2011) Preopera-tive Ultrasound-Guided Needle Biopsy of Axillary Nodes in Invasive Breast Cancer: Meta-Analysis of Its Accuracy and Utility in Staging the Axilla. Annals of Surgery, 254, 243-251. https://doi.org/10.1097/SLA.0b013e31821f1564
|
[35]
|
Wu, J., Zhang, H., Li, L., et al. (2020) A Nomogram for Predicting Overall Survival in Patients with Low-Grade Endometrial Stromal Sarcoma: A Population-Based Analysis. Cancer Communications (Lond), 40, 301-312.
https://doi.org/10.1002/cac2.12067
|